A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
Clinical trial NCT06556368 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06556368
- Sponsor
- Kodiak Sciences Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2026-08-01
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.